TargetMol

Irampanel

Product Code:
 
TAR-T27626
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T27626-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27626-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27626-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Irampanel is a neuroprotectant and anticonvulsant.
CAS:
206260-33-5
Formula:
C18H19N3O2
Molecular Weight:
309.369
Purity:
0.98
SMILES:
CN(C)CCOc1ccccc1-c1nc(no1)-c1ccccc1

References

1. Feigin V. Irampanel Boehringer Ingelheim. Curr Opin Investig Drugs. 2002 Jun;3(6):908-10. Review. PubMed PMID: 12137411. 2. Wienrich M, Brenner M, L?scher W, Palluk R, Pieper M, Potschka H, Weiser T. In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels. Br J Pharmacol. 2001 Jul;133(6):789-96. PubMed PMID: 11454651; PubMed Central PMCID: PMC1572840. 3. Weiser T, Wienrich M, Brenner M, Kubiak R, Weckesser G, Palluk R. The AMPA receptor/Na(+) channel blocker BIIR 561 CL is protective in a model of global cerebral ischaemia. Eur J Pharmacol. 2001 Jun 15;421(3):165-70. PubMed PMID: 11516432. 4. Weiser T, Iizuka M, Nishimura S, Akiba I, Barsoumian E, Zhou M, Steinh?user C, Brenner M, Palluk R, Wienrich M. Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):419-26. PubMed PMID: 11111837.